Dipyridamole in the treatment of dengue haemorrhagic fever.

Simple item page
dc.contributor.authorKho, L Ken_US
dc.contributor.authorWulur, Hen_US
dc.contributor.authorHimawan, Ten_US
dc.date.accessioned2009-05-27T16:08:14Z
dc.date.available2009-05-27T16:08:14Z
dc.date.issued1979-09-01en_US
dc.descriptionThe Southeast Asian Journal of Tropical Medicine and Public Health.en_US
dc.description.abstractClinical studies in the treatment of 54 children suffering from DHF with a combination of dipyridamole and ASA as an adjuvant of our standard therapy consisted of fluid, electrolytes, blood, plasma and plasma expanders were evaluated. Heparin was administered in cases of DIC. It appeared that dipyridamole and ASA did not change the mortality significantly, but it prevented the progress of the severity of the disease from grade I and II to grade III and IV.en_US
dc.identifier.citationKho LK, Wulur H, Himawan T. Dipyridamole in the treatment of dengue haemorrhagic fever. The Southeast Asian Journal of Tropical Medicine and Public Health. 1979 Sep; 10(3): 385-8en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/34502
dc.language.isoengen_US
dc.source.urihttps://www.tm.mahidol.ac.th/seameo/publication.htmen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAspirin --therapeutic useen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshDengue --drug therapyen_US
dc.subject.meshDipyridamole --therapeutic useen_US
dc.subject.meshDisseminated Intravascular Coagulation --prevention & controlen_US
dc.subject.meshDrug Therapy, Combinationen_US
dc.subject.meshHeparin --therapeutic useen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.titleDipyridamole in the treatment of dengue haemorrhagic fever.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Southeast Asian Journal of Tropical Medicine and Public Health